Anti-Inflammatory Plant-Based and Succinate-Based Supplements for Perimenopausal Anxiety and Insomnia
For a perimenopausal woman seeking non-hormonal options for anxiety and insomnia, start with cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, then consider gabapentin 300-900 mg at night for sleep disturbance, and if seeking supplements specifically, succinate-based compositions show the most direct evidence for perimenopausal symptoms including anxiety and insomnia, while anti-inflammatory plant supplements like curcumin and boswellia have general anti-inflammatory properties but lack specific evidence for perimenopausal mood and sleep symptoms.
Evidence-Based Treatment Algorithm
First-Line Approach (Strongest Evidence)
- CBT-I remains the gold standard for insomnia in perimenopausal women, with strong recommendation from multiple guidelines 1
- Implement sleep hygiene: avoid caffeine and alcohol, eliminate bedroom noise, maintain regular sleep schedule, limit daytime napping to 30 minutes before 2 PM 2, 3
- Consider gabapentin 300-900 mg at night for sleep disturbance—this has specific evidence in perimenopausal women and improves both sleep quality and duration 2
Pharmacologic Options for Anxiety and Sleep
When non-pharmacologic approaches are insufficient:
- SSRIs/SNRIs (paroxetine 10-20 mg, citalopram 10-30 mg, escitalopram 10-20 mg, or venlafaxine 75 mg) reduce vasomotor symptoms by 50-60% and can address comorbid anxiety 2
- Melatonin 3 mg showed improvement in subjective sleep quality in one RCT of perimenopausal women without significant adverse effects 2
- Consider augmenting SSRI/SNRI with zolpidem 5-10 mg if sleep remains problematic 2
Supplement-Specific Evidence
Succinate-Based Supplements
Succinate-based dietary supplements (SBDS) have the most direct evidence for perimenopausal symptoms:
- A pooled analysis of two identical RCTs (n=227 women aged 42-60) demonstrated that SBDS significantly improved 16 of 21 menopausal symptoms and decreased anxiety (p<0.0001) compared to placebo 4
- An earlier study showed SBDS alleviated hot flushes, headache, and anxiety while increasing serum estradiol levels fourfold 5
- Mechanism: Succinate is an energy-exchange metabolite that appears to modulate hormonal balance without direct hormone replacement
- Dosing: Based on the commercial product "Amberen" used in trials—specific dosing follows manufacturer recommendations
- Safety profile: Appeared free of adverse side effects in clinical trials 5, 4
Anti-Inflammatory Plant-Based Supplements
The evidence for plant supplements specifically targeting perimenopausal anxiety and insomnia is limited, but several show promise:
Supplements with Some Clinical Evidence:
Curcuma longa (Turmeric/Curcumin): Systematic review shows anti-inflammatory properties but requires further investigation for specific inflammatory conditions 6. A 2025 meta-analysis found anti-inflammatory medicinal plant supplements improved menopause-like symptoms and psychological problems, with network analysis showing response rates as the most associated factor 7
Boswellia serrata: Shows the best efficacy for pain/inflammatory conditions among reviewed botanicals, though specific perimenopausal data is lacking 6
Withania somnifera (Ashwagandha): Demonstrated anxiolytic and stress-reducing effects through modulation of the HPA axis and anti-inflammatory pathways 8
Crocus sativus (Saffron) and Curcuma longa: Show antidepressant effects via monoaminergic modulation and anti-inflammatory mechanisms 8
Important Caveats About Plant Supplements:
Guidelines explicitly caution against over-the-counter supplements:
- The American Association of Clinical Endocrinologists states: "Over-the-counter supplements should be used with caution because they are not regulated by the FDA and have the potential for interactions with drugs and for causing harm" 9
- Multiple sleep medicine guidelines note that herbal substances like valerian and melatonin "are not recommended in the treatment of chronic insomnia due to the relative lack of efficacy and safety data" 10
- Phytoestrogens (including soy) show inconsistent relief and should be avoided in women with hormone-dependent cancer history 9
Significant Safety Concerns:
- Plant supplements can cause cytochrome P450-mediated drug interactions, excessive sedation, serotonin syndrome, and hepatotoxicity 8
- Product adulteration is a major concern with cardiovascular and neurological risks 8
- St. John's Wort (Hypericum perforatum), while effective for depression, has extensive drug interactions 8
Practical Clinical Approach
Step 1: Non-Pharmacologic Foundation
- Implement CBT-I (available online) 2
- Optimize sleep hygiene 2, 3
- Encourage regular aerobic exercise—shown to improve both sleep quality and anxiety in perimenopausal women 11
Step 2: If Supplements Are Specifically Requested
Succinate-based supplements have the strongest direct evidence for perimenopausal anxiety and insomnia 5, 4
If considering anti-inflammatory plant supplements:
- Curcumin or Boswellia serrata for general anti-inflammatory effects 6
- Ashwagandha for anxiety 8
- Monitor closely for herb-drug interactions and adverse effects
- Ensure products are from reputable manufacturers with third-party testing
Step 3: Consider Prescription Options
If symptoms persist:
- Gabapentin 300-900 mg at night for sleep 2
- SSRI/SNRI for anxiety and vasomotor symptoms 2
- Melatonin 3 mg as adjunct 2
Critical Warnings
Tryptophan and GABA pathway modulation through diet shows theoretical promise but lacks clinical validation in perimenopausal women 12
One in three perimenopausal women experiences depressive, anxiety, or insomnia symptoms—routine mental health screening is essential 13
Avoid antihistamines for chronic insomnia—limited efficacy data and anticholinergic side effects 10, 3
Quality control matters: Plant supplements lack FDA regulation, making product quality variable and potentially dangerous 9, 8
The evidence hierarchy clearly favors CBT-I first, then gabapentin or SSRIs/SNRIs for persistent symptoms. Among supplements, succinate-based formulations have the most direct clinical evidence for perimenopausal anxiety and insomnia, while anti-inflammatory plant supplements have theoretical benefits but require careful monitoring for safety 2, 5, 4, 8.